To further evaluate the B cell response of patients with COVID-19, we produced and selected 9 monoclonal antibodies from convalescent COVID-19 patients by isolating CD20+ memory B cells reactive against both the receptor-binding domain (RBD) and S1 of SARS-CoV-2 and examined their reactivity against self-antigens. Here, PSMD1 is linked to COVID-19.